News Search Results
Nov 08, 2023, 17:01 ET Ginkgo Bioworks Reports Third Quarter 2023 Financial Results
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Nov 08, 2023, 15:14 ET Researchers Assemble Nine Synthetic Yeast Chromosomes
versus those that do not. "Manipulating synIV's 3D structure paves the way for fully predictable 3D genome engineering—a major advance in synthetic biology enabling us to define how synthetic genomes are packaged and regulated within a cell," noted Dr. Zhang. Finally, the Luo et al. team uncovered
More news about: NYU Grossman School of Medicine and NYU Langone Health
Nov 08, 2023, 09:00 ET Stanford to use Sequentify kits for Hematological Malignancies NGS Sequencing
/PRNewswire/ -- Sequentify, a Weizmann Institute spinoff that develops synthetic biology and AI software to enable rapid targeted DNA sequencing, is pleased to announce Stanford Institute for Stem Cell Biology and Regenerative Medicine
More news about: Sequentify
Nov 08, 2023, 08:00 ET Molecular Assemblies Receives the 2023 BioServices Innovation of the Year Award from BioTech Breakthrough Awards Program
including sequences not available today. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. Molecular
More news about: Molecular Assemblies, Inc.
Nov 07, 2023, 02:32 ET IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing
of natural rubber; it can also act as a precursor for sustainable aviation fuel, solvents, cosmetics, and textiles. One startup, Visolis, used synthetic biology to develop a microbe that biosynthesizes mevalonic acid and is now looking to push into the production of biobased isoprene and sustainable aviation
More news about: IDTechEx
Nov 06, 2023, 07:00 ET Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Nov 03, 2023, 17:35 ET Biohacking Market size to grow by USD 32.68 billion from 2023-2028| Apalon LLC, Apple Inc., Beeblesoft Ltd., Biohacker Center Store, Biohackers Health and Fitness and more among the key companies - Technavio
Profile: Segmentation Analysis The market has segmented by Product (Wearables and Smart drugs), Application (Forensic science, Synthetic biology, Genetic engineering, and Others), and Geography (North America, Asia,
More news about: Technavio
Nov 03, 2023, 10:58 ET New England Biolabs® Launches New NEBNext UltraExpress™ DNA and RNA Kits for Faster, Easier NGS Library Prep Workflows
NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key
More news about: New England Biolabs
Nov 03, 2023, 08:17 ET PIPA, The AI Leader For R&D Innovation Accelerates Growth with Addition of John Melo as CEO
self-funded, and profitable AI companies in the sector. John Melo has been a trailblazer in the realm of Synthetic Biology. With over 25 years of leadership experience in sustainable innovations, his journey has been marked by numerous breakthroughs in Biotechnology,
More news about: PIPA
Nov 01, 2023, 08:30 ET Kyverna Therapeutics Announces Collaboration with Charité to Fund Research into B-Cell and Plasma Cell-Targeting Therapies in Patients with Autoimmune Diseases
a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline
More news about: Kyverna Therapeutics
Oct 31, 2023, 08:31 ET OpenCell Technologies Appoints Biotech Veteran Dr. Behzad Mahdavi as Executive Chairman of the Board of Directors
technology platform for continuous and scalable transfection that opens new frontiers for cellular engineering in emerging cell & gene therapy and synthetic biology markets. ST. LOUIS, Oct.
More news about: OpenCell Technologies Inc.
Oct 30, 2023, 10:00 ET Think Bioscience Appoints Wendy Young, Ph.D., to its Scientific Advisory Board
Oct. 30, 2023 /PRNewswire/ -- Think Bioscience ("Think"), a Boulder-based synthetic biology company focused on developing small-molecule therapeutics that target "undruggable" proteins, has appointed
More news about: Think Bioscience
Oct 26, 2023, 12:45 ET Plant-based material science company Algenesis secures new funding to scale production and fight climate change
TX, First Bight Ventures is an early-stage fund dedicated to advancing and accelerating synthetic biology companies. Leveraging its industry partners, First Bight aims to bring innovation in synthetic biology to industries and accelerate the Bioeconomy, with the goal of delivering a more sustainable
More news about: First Bight Ventures
Oct 26, 2023, 10:15 ET Global Second Generation Biofuels Industry Report 2023: Biofuels Beyond Food Crops, Transitioning to a Sustainable Energy Future
on SoilH.5 Impact on WaterH.6 Impact on Biodiversity I. Second Generation Biofuels and Genetic Engineering J. Synthetic Biology for Second Generation Biofuels K. Commercial Investment in Second Generation BiofuelsK.1 OverviewK.2 Investment CostsK.3
More news about: Research and Markets
Oct 26, 2023, 09:17 ET GOODYEAR AND VISOLIS TO COLLABORATE ON THE PRODUCTION OF ISOPRENE BY UPCYCLING MATERIALS
ranging from personal care to apparel and transportation achieve net zero emission targets. The Visolis platform combines artificial intelligence, synthetic biology and chemical catalysis to efficiently produce a portfolio of carbon negative chemicals and net-zero emissions sustainable aviation fuels. Visolis'
More news about: The Goodyear Tire & Rubber Company
Oct 26, 2023, 08:00 ET Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
N.Y., Oct. 26, 2023 /PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced the presentation of preclinical
More news about: Codagenix Inc.
Oct 25, 2023, 23:00 ET New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
of healthcare products; companion animal and livestock health; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. ERS holds over 100 patents worldwide. For additional information, please visit www.ersgenomics.com
More news about: ERS Genomics
Oct 24, 2023, 10:55 ET TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power
In a candid and enlightening discussion, Zhiqian, shared his entrepreneurial journey and the evolution of TidetronBioworks, a leading synthetic biology technology company focused on revolutionizing sustainable platforms and production. Visioning a future where technology innovation shapes a better
More news about: Tidetron Bioworks
Oct 24, 2023, 10:31 ET TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power
In a candid and enlightening discussion, Zhiqian, shared his entrepreneurial journey and the evolution of TidetronBioworks, a leading synthetic biology technology company focused on revolutionizing sustainable platforms and production. Visioning a future where technology innovation shapes a better
More news about: Tidetron Bioworks
Oct 24, 2023, 09:00 ET LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab
experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering. Juvenescence has a broad portfolio of products in development and is driving innovation, with a focus
More news about: LyGenesis, Inc.
Oct 24, 2023, 08:00 ET Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine
N.Y., Oct. 24, 2023 /PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced that the US Department of Defense
More news about: Codagenix Inc.
Oct 24, 2023, 07:00 ET Concentric by Ginkgo Partners with Penn State University on Zoonotic Disease Biosurveillance Research Supported by USDA Grant
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 23, 2023, 11:00 ET Fermbox Bio Enters into a Strategic JV with BBGI to Establish Large-Scale Precision Fermentation Synbio Plant in Thailand and SEA
Initially, these precision fermentation facilities will focus on enzyme production, expanding into innovative Synthetic Biology (Synbio) products for global customers with an expected total fermentation capacity of up to 1 million liters, equipped with the state of art
More news about: Fermbox Bio
Oct 23, 2023, 07:00 ET Ayana Bio Launches Plant Cell Advantage™ Portfolio with Three New Health and Wellness Ingredients
provide consumers with confidence in quality and reliability. Ayana Bio has partnered with Ginkgo Bioworks, a synthetic biology platform company that is redesigning the living world to solve some of the globe's growing challenges in health, energy, food, material, and more.
More news about: Ayana Bio
Oct 20, 2023, 03:19 ET Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens
the cutting-edge domains of synthetic biology, gene therapy, and medical robotics, positioning itself as the "first mover" in China. To elaborate, the "Action Plan of Shanghai for Accelerating Synthetic Biology Innovation Incubation and
More news about: Shanghai Biomedical Industry Promotion Center